Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 102650205 | 10265020 | 5 | F | 20160706 | 20140627 | 20160711 | EXP | US-PFIZER INC-2014176408 | PFIZER | 55.00 | YR | F | Y | 0.00000 | 20160711 | CN | US | US |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 102650205 | 10265020 | 1 | PS | AROMASIN | EXEMESTANE | 1 | UNK | 20753 | COATED TABLET | ||||||||||
| 102650205 | 10265020 | 2 | SS | AROMASIN | EXEMESTANE | 1 | UNK | X270F | 20753 | COATED TABLET | |||||||||
| 102650205 | 10265020 | 3 | C | VENLAFAXINE | VENLAFAXINE HYDROCHLORIDE | 1 | 37.5 MG, UNK | 0 | 37.5 | MG |
Indications of drugs used
| no results found |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 102650205 | 10265020 | OT |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 102650205 | 10265020 | Bone pain | |
| 102650205 | 10265020 | Feeling abnormal | |
| 102650205 | 10265020 | Headache | |
| 102650205 | 10265020 | Memory impairment | |
| 102650205 | 10265020 | Parosmia | |
| 102650205 | 10265020 | Suicidal ideation | |
| 102650205 | 10265020 | Vaginal haemorrhage | |
| 102650205 | 10265020 | Visual impairment | |
| 102650205 | 10265020 | Vulvovaginal dryness | |
| 102650205 | 10265020 | Vulvovaginal pruritus |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| no results found |